Vitamin D3 supplements help reverse early cervical neoplasia

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

 

  • Supplementation with vitamin D3 administered for 6 mo resulted in regression of cervical intraepithelial neoplasia grade 1 (CIN-1) and also improved glucose homeostasis parameters.

Why this matters

 

 

  • These findings suggest that vitamin D3 supplementation can benefit women with CIN-1.

Study design

 

 

  • Randomized, placebo-controlled trial composed of 58 women diagnosed with CIN1; cohort was randomly assigned to 50,000 IU vitamin D3 supplements (n=29) or placebo (n=29), taken every 2 wk for 6 mo.
  • Funding: Vice-chancellor for Research, KUMS, and Iran.

Key results

 

 

  • A higher percentage in the vitamin D group showed regression of CIN1 (84.6% vs 53.8%; P=.01) vs placebo.
  • The vitamin D group showed a significant decrease in serum insulin levels (−5.3±7.3 vs +2.4±5.9 μIU/mL; P<.001), insulin resistance (−1.2±1.6 vs +0.5±1.2; P<.001), and β-cell function (P=.005), and a significant rise in quantitative insulin sensitivity check index (+0.03±0.04 vs −0.007±0.02; P<.001).
  • Significant increases in plasma nitric oxide were also noted (+15.5±10.3 vs +4.0±13.4 μmol/L; P=.001).
Limitations
  • Unable to assess the effect of vitamin D supplementation on HPV.